- Home
- BYD vs GKOS Comparison
BYD vs GKOS Comparison
Compare BYD & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYD | GKOS |
|---|---|---|
| Founded | 1973 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.4B |
| IPO Year | 1993 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BYD | GKOS |
|---|---|---|
| Price | $80.23 | $107.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | $89.57 | ★ $122.08 |
| AVG Volume (30 Days) | 722.3K | ★ 1.0M |
| Earning Date | 10-23-2025 | 10-29-2025 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 325.66 | N/A |
| EPS | ★ 22.22 | N/A |
| Revenue | ★ $4,070,839,000.00 | $469,820,000.00 |
| Revenue This Year | $2.59 | $31.15 |
| Revenue Next Year | N/A | $24.15 |
| P/E Ratio | $3.59 | ★ N/A |
| Revenue Growth | 5.91 | ★ 30.38 |
| 52 Week Low | $58.94 | $73.16 |
| 52 Week High | $88.49 | $163.71 |
Technical Indicators
Market Signals| Indicator | BYD | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 72.63 |
| Support Level | $81.62 | $107.28 |
| Resistance Level | $82.89 | $112.00 |
| Average True Range (ATR) | 1.55 | 3.84 |
| MACD | -0.06 | 0.48 |
| Stochastic Oscillator | 36.46 | 81.13 |
Price Performance
Historical ComparisonAbout BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.